All In Biotech

Drug Trial Radar · NCT05540665

Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Evaluating the Efficacy and Safety of Daxdilimab in Adult Participants With Active Proliferative Lupus Nephritis

Last checked: Nov 19, 2026Latest source record: Mar 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

19

Actual

Start

Apr 26, 2023

Primary completion

Jan 4, 2024

Study completion Jan 4, 2024

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Sep 15, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 2, multicenter, double-blind, randomized, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of daxdilimab in patients with active, proliferative lupus nephritis (LN).

Conditions

  • Lupus Nephritis

Interventions

  • DaxdilimabDrug

    Daxdilimab will be administered subcutaneously as two injections for each dose. Other Names: HZN-7734

  • DaxdilimabDrug

    Daxdilimab will be administered subcutaneously as two injections for each dose. Other Names: HZN-7734

  • Placebo (Normal Saline)Drug

    Placebo will be administered subcutaneously as two injections for each dose.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Achieved CRR at Week 48 Through Week 52Time frame: Week 48 to Week 52

Locations

52 sites in 12 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • California Kidney Specialists

    San Dimas, California

  • SUNY Upstate Medical University

    Syracuse, New York

  • DaVita Clinical Research - El Paso

    El Paso, Texas

  • Care and Cure Clinic

    Houston, Texas

  • DOM Centro de Reumatologia

    Buenos Aires, Argentina

  • Aprillus Asistencia e Investigacion de Arcis Salud SRL

    Buenos Aires, Argentina

  • Consultorios Médicos Dr. Doreski

    Buenos Aires, Argentina

  • Swiss Medical Center Barrio Parque

    Ciudad Autónoma Buenos Aires, Argentina

  • Centro de Investigaciones Médicas Tucumán

    San Miguel de Tucumán, Argentina

  • Clinica Mayo de U.M.C.B. S.R.L

    San Miguel de Tucumán, Argentina

  • Framingham Centro Médico

    La Plata, Buenos Aires, Argentina

  • Instituto Médico de la Fundación Estudios Clínicos

    Rosario, Santa Fe Province, Argentina

  • Oncovida- Centro de Onco-Hematologia de Mato Grosso

    Cuiabá, Brazil

  • Hospital Das Clinicas da Faculdade de Medicina de Ribeirão Preto - USP - PPDS

    Ribeirão Preto, Brazil

  • Praxis Pesquisa Medica

    Santo André, Brazil

  • Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

    São Paulo, Brazil

  • Praxis Pesquisa Medica

    São Paulo, Brazil

  • SER - Serviços Especializados em Reumatologia da Bahia S/S - ME

    Salvador, Estado de Bahia, Brazil

  • Clinica Senhor Do Bonfim CSB

    Salvador, Estado de Bahia, Brazil

  • Santa Casa de Misericórdia de Belo Horizonte - PPDS

    Belo Horizonte, Minas Gerais, Brazil

  • Centro Mineiro de Pesquisa

    Juiz de Fora, Minas Gerais, Brazil

  • Irmandade Da Santa Casa de Misericordia de Porto Alegre

    Porto Alegre, Rio Grande do Sul, Brazil

  • LMK Servicos Medicos SS

    Porto Alegre, Rio Grande do Sul, Brazil

  • Clinical Hospital Centre Osijek

    Osijek, Croatia

  • Lady Davis Carmel Medical Center

    Haifa, Central District, Israel

  • Meir Medical Center

    Kfar Saba, Central District, Israel

  • Sheba Medical Center - PPDS

    Ramat Gan, Tel Aviv, Israel

  • Hospital Serdang

    Kajang, Malaysia

  • Hospital Putrajaya

    Putrajaya, Malaysia

  • University Malaya Medical Centre

    Kuala Lumpur, Kuala Lumpur, Malaysia

  • Mary Mediatrix Medical Center

    Lipa City, Batangas, Philippines

  • St. Paul's Hospital

    Iloilo City, Iloilo, Philippines

  • GreenCity Medical Center

    San Fernando City, Pampanga, Philippines

  • Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. Prof. Dr hab. Med. Eleonory Reicher

    Warsaw, Poland

  • Wojskowy Instytut Medyczny - Panstwowy Instytut Badawczy

    Warsaw, Poland

  • SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im Norberta Barlickiego Uniwersytetu Medycznego w Lodzi

    Lodz, Lódzkie, Poland

  • Institute of Rheumatology Belgrade - PPDS

    Belgrade, Serbia

  • Military Medical Academy

    Belgrade, Serbia

  • General Hospital Krusevac

    Kruševac, Serbia

Showing 40 of 52 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.